Revolution Medicines (RVMD) Shares Issued (2019 - 2026)
Revolution Medicines (RVMD) posted quarterly Shares Issued of $19.4 million for Q1 2026, up 137.5% year-over-year from $8.2 million in Q1 2025, and up 8.02% quarter-over-quarter from $18.0 million in Q4 2025.
Revolution Medicines (RVMD) Shares Issued (2019 - 2026) Analysis & Trends
Revolution Medicines' Shares Issued history runs 8 years deep, the most recent figure standing at $19.4 million for Q1 2026.
- In Q1 2026, Shares Issued rose 137.5% year-over-year to $19.4 million; the TTM figure through Mar 2026 stood at $19.4 million (up 137.5% YoY), while the FY2025 annual figure was $18.0 million, up 28.69% from the prior year.
- Shares Issued for Q1 2026 stood at $19.4 million, up from $18.0 million in the prior quarter.
- The five-year high for Shares Issued was $19.4 million in Q1 2026, with the low at $3.8 million in Q2 2022.
- The 5-year median for Shares Issued is $8.2 million (2022), against an average of $10.2 million.
- The sharpest annual moves came in 2023 and 2025: Shares Issued plunged 38.06% in 2023, then jumped 148.21% in 2025.
- Revolution Medicines' Shares Issued stood at $8.2 million in 2022, then surged by 35.75% to $11.1 million in 2023, then climbed by 26.19% to $14.0 million in 2024, then advanced by 28.69% to $18.0 million in 2025, then advanced by 8.02% to $19.4 million in 2026.
- Business Quant data shows RVMD's Shares Issued at $19.4 million in Q1 2026, $18.0 million in Q4 2025, and $17.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.36 Mn |
| Jun 30, 2026 | 18.36 Mn |
| Mar 31, 2026 | 19.44 Mn |
| Mar 31, 2026 | 19.44 Mn |
| Dec 31, 2025 | 18.00 Mn |
| Dec 31, 2025 | 18.00 Mn |
| Sep 30, 2025 | 17.65 Mn |
| Sep 30, 2025 | 17.65 Mn |
| Jun 30, 2025 | 17.27 Mn |
| Jun 30, 2025 | 17.27 Mn |
| Mar 31, 2025 | 8.19 Mn |
| Mar 31, 2025 | 8.19 Mn |
| Dec 31, 2024 | 13.99 Mn |
| Dec 31, 2024 | 13.99 Mn |
| Sep 30, 2024 | 14.08 Mn |
| Sep 30, 2024 | 14.08 Mn |
| Jun 30, 2024 | 6.96 Mn |
| Jun 30, 2024 | 6.96 Mn |
| Mar 31, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.40 Mn |